Recognizing metronidazole resistant c. difficile

Nurse Practitioner

Volumn 36, Issue 11, 2011, Pages 8-11

  Gardner, Elizabeth ^a   Meghani, Nosheen ^a   Mancuso, Peggy ^a   Thomson, Anne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METRONIDAZOLE; PROBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DRUG COMBINATION; FEMALE; HUMAN; MIDDLE AGED; OPPORTUNISTIC INFECTION; PSEUDOMEMBRANOUS COLITIS; RECURRENT DISEASE;

ANTI-INFECTIVE AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; METRONIDAZOLE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PROBIOTICS; RECURRENCE; VANCOMYCIN;

EID: 84857413271     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000406494.92038.ae     Document Type: Article

References (19)

1. Gerding DN, Johnson S. Clostridium difficile-associated disease, including pseudomembranous colitis. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, eds. Harrison’s Principles of Internal Medicine. 17th ed. New York, NY: McGraw-Hill; 2008.
2. Chow AW. Anaerobic infections. In: Dale D, ed. Infectious Diseases: The Clinician’s Guide to Diagnosis, Treatment and Prevention. New York, NY: Web MD; 2010.
3. Yoo J, Lightner AL. Clostridium difficile infections: what every clinician should know. Perm J. 2010;14(2):35-40.
4. Best EL, Fawley WN, Parnell P, Wilcox MH. The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin Infect Dis. 2010;50(11):1450-1457.
5. Wieczorkiewicz JE, Lopansri BK, Tomich AZ, Zurkowski E, Sambol SP, Gerding DN. Fluoroquinolone use is a specific risk factor for Clostridium difficile infection due to the highly fluoroquinolone resistant epidemic strain BI/NAP1 [Abstract]. In: Fifth Decennial International Conference on Healthcare-Associated Infections. March 18-22, 2010. Atlanta, GA.
6. Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009;30(1):57-66.
7. Razavi B, Apisarnthanarak A, Mundy L. Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. Infection. 2007;35(5):300-307.
8. Centers for Disease Control and Prevention (CDC). Healthcare-associated infections: Clostridium difficile Infection (CDI, C. diff). http://www.cdc.gov/HAI/organisms/cdiff/Cdiff_infect.html.
9. Sayeed S, McGiffert L, McCauley M. Consumers Union policy brief: Hospital-acquired C. difficile infections. http://www.consumersunion.org/pub/Final%20Cdiff%20Policy%20Brief%2011-11-08.pdf.
10. Centers for Disease Control and Prevention. Healthcare-associated infections: Frequently Asked Questions about Clostridium difficile for Healthcare Providers. http://www.cdc.gov/HAI/organisms/cdiff/Cdiff_faqs_HCP.html.
11. Kelly CP, Lamont JT. Treatment of Clostridium difficile infection in adults. http://www.uptodate.com/contents/treatment-of-clostridium-difficile-infection-in-adults.
12. Kelly CP, LaMont JT. Patient information: Antibiotic-associated diarrhea (Clostridium difficile). http://www.uptodate.com/patients/content/topic.do?topicKey=6y86CpJTTR1ZzRx.
13. Higginson R. Infection control and IV therapy in patients with Clostridium difficile. Br J Nurs. 2009;18(16):962-969.
14. McQuaid KR. Gastrointestinal Disorders. In: Mcphee SJ, Papadakis MA, eds. Current Medical Diagnosis and Treatment. 49th ed. New York, NY: McGraw Hill; 2010:503-597.
15. Williams NT. Probiotics. Am J Health Syst Pharm. 2010;67(6):449-458.
16. Johnson BC, Thorlund K. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children (Protocol). Cochrane Database Syst Rev. 2009;(1).
17. Pillai A, Nelson RL. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev. 2008;(1).
18. Khoruts A, Sadowski MJ. Therapeutic transplantation of the distal gut microflora. Mucosal Immunol. 2011;4(1):4-7.
19. Hundal R, Kassam Z, Johnson J, Lee C. Fecal transplantation for recurrent or refractory Clostridium difficile diarrhea(Protocol). Cochrane Database of Systematic Reviews. 2011;(9).